CARROLL J MARTIN — SEC Form 4 filings

SEC reporting owner CIK 1279901. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-05-24 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Esperion Therapeutics, Inc. (ESPR)Director49
Catalent, Inc. (CTLT)Director22

Form 4 filings — CARROLL J MARTIN

FiledFormIssuerReported transactionsSource
2026-07-134Esperion Therapeutics, Inc. (ESPR)Disposition to issuer (D): 177,523 · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 32,500 (derivative) · Disposition to issuer (D): 44,000 (derivative)EDGAR
2026-06-014Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 79,873 @ $0EDGAR
2025-06-024Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 33,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0EDGAR
2024-12-184Catalent, Inc. (CTLT)Disposition to issuer (D): 32,734EDGAR
2024-11-014Catalent, Inc. (CTLT)Grant/award (A): 4,663 @ $0EDGAR
2024-05-244Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 23,000 @ $0 · Grant/award (A): 32,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1279901 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →